This meta-analysis included 6232 allele records of prostate cancer cases and, respectively, 6015 controls from 10 original published studies that explored the association between a potentially functional polymorphism of CYP3A4 and the susceptibility to the disease (Table S2). This evidence concerns the gene CYP3A4 and prostate carcinoma.